top of page
Ancla 1
Our Platform
Two different lung-specific bacterial chassis (MycoChassis and LactoChassis), designed to treat acute and chronic respiratory diseases, respectively. These chassis are able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner.
IMMUNE SYSTEM MODULATION
ANTIMICROBIAL AND BIOFILM DISPERSION
ACUTE
PROTEIN SUPPLEMENTATION
FOR GENETIC DISEASES
Chronic obstructive
Pulmonary disease
A1AT
Interstitial lung disease
Surfactant proteins
Publications by scientific team
bottom of page